RecruitingPhase 4NCT06972056
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
Sponsor: Mayo Clinic
Charlotte, NC · +34 more sites
Clinical trials in Salisbury, NC
10 recruiting studies have a site in or near Salisbury, NC, North Carolina.
Top conditions here
- Breast Cancer (3)
- Prostate Cancer (2)
- Lung Cancer (1)
- Psoriasis (1)
- Rheumatoid Arthritis (1)
- Migraine (1)
- COPD (1)
All conditions
- Alzheimer's Disease
- Asthma
- Breast Cancer
- COPD
- Crohn's Disease
- Depression
- Type 1 Diabetes
- Type 2 Diabetes
- Heart Failure
- Hypertension
- Leukemia
- Lung Cancer
- Lupus
- Migraine
- Multiple Sclerosis
- Obesity
- Parkinson's Disease
- Prostate Cancer
- Psoriasis
- Rheumatoid Arthritis
- Schizophrenia
- Sickle Cell Disease
- Ulcerative Colitis
- Colorectal Cancer
Showing 10 of 10 studies
RecruitingPhase 3NCT06283966
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
Sponsor: AstraZeneca
Fayetteville, NC · Greensboro, NC · Greenville, NC · +232 more sites
RecruitingPhase 2NCT07321873
A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis
Sponsor: Janssen Research & Development, LLC
Charlotte, NC · Salisbury, NC · +16 more sites
RecruitingPhase 3NCT06357533
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Sponsor: AstraZeneca
Greenville, NC · Salisbury, NC · +61 more sites
RecruitingPhase 2NCT05011383
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
Sponsor: VA Office of Research and Development
Durham, NC · Salisbury, NC · +15 more sites
RecruitingPhase 3NCT05879926
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Sponsor: NRG Oncology
Albemarle, NC · Asheboro, NC · +1223 more sites
RecruitingPhase 3NCT05812807
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Sponsor: Alliance for Clinical Trials in Oncology
Albemarle, NC · Asheboro, NC · +825 more sites
RecruitingPhase 2NCT05422911
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
Sponsor: Sun Pharmaceutical Industries Limited
Salisbury, NC · +11 more sites
RecruitingPhase 3NCT06747949
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
Sponsor: Amgen
Charlotte, NC · Durham, NC · Salisbury, NC · +28 more sites
RecruitingPhase 3NCT04852887
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Sponsor: NRG Oncology
Albemarle, NC · Asheville, NC · +809 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.